FindTrial
Sign In

Asbestos related lung cancer-A Pilot Study

The role of microRNAs as biomarkers of asbestos-related lung cancers: A PilotStudy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091788
Enrollment
50
Registered
2025-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J689- Unspecified respiratory conditiondue to chemicals, gases, fumes and vapors

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Regional Administration of Sardinia, Italy.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Worker should be Indian.

Exclusion criteria

Exclusion criteria: 1) Worker having past or current history of cancer. 2) Pregnant woman. 3) Lactating woman.

Design outcomes

Primary

MeasureTime frame
The aim of the pilot study is to compare the expression of miRNA in exhaled breath condensate (EBC) and blood (gold standard), between the malignant pleural mesothelioma patients or asbestos exposed lung cancer patients and current or former asbestos exposed cancer free controls to identify reliable biomarkers of cancer.Timepoint: 1 year—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Sharayu Mhatre

Molecular Epidemiology & Population Genomics Centre for Cancer Epidemiology (CCE)

mhatresharayu@gmail.com9137792085

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026